Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Calderaro

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
Journal of Hepatology|February 10, 2022
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histologyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2017
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic modelsCharlotte E Costentin, Giuliana Amaddeo, Thomas Decaens, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
NPJ Precision Oncology|May 23, 2024
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathologyMarco Gustav, Nic Gabriel Reitsam, Zunamys I Carrero, et al.
Journal of Hepatology|December 18, 2020
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetMassih Ningarhari, Stefano Caruso, Théo Z Hirsch, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Journal of Hepatology|December 22, 2019
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKAThéo Z Hirsch, Ana Negulescu, Barkha Gupta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR CohortMarion Delplanque, Xavier Amiot, Dominique Wendum, et al.
Nature Communications|February 10, 2024
Regression-based Deep-Learning predicts molecular biomarkers from pathology slidesOmar S M El Nahhas, Chiara M L Loeffler, Zunamys I Carrero, et al.
Gut|August 4, 2019
Adeno-associated virus in the liver: natural history and consequences in tumour developmentTiziana La Bella, Sandrine Imbeaud, Camille Peneau, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Journal of Hepatology|February 10, 2022
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histologyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2017
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic modelsCharlotte E Costentin, Giuliana Amaddeo, Thomas Decaens, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
NPJ Precision Oncology|May 23, 2024
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathologyMarco Gustav, Nic Gabriel Reitsam, Zunamys I Carrero, et al.
Journal of Hepatology|December 18, 2020
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetMassih Ningarhari, Stefano Caruso, Théo Z Hirsch, et al.
International Journal of Cancer|October 6, 2018
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseasesJie Yang, Eric Trépo, Pierre Nahon, et al.
Journal of Hepatology|December 22, 2019
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKAThéo Z Hirsch, Ana Negulescu, Barkha Gupta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR CohortMarion Delplanque, Xavier Amiot, Dominique Wendum, et al.
Nature Communications|February 10, 2024
Regression-based Deep-Learning predicts molecular biomarkers from pathology slidesOmar S M El Nahhas, Chiara M L Loeffler, Zunamys I Carrero, et al.
Gut|August 4, 2019
Adeno-associated virus in the liver: natural history and consequences in tumour developmentTiziana La Bella, Sandrine Imbeaud, Camille Peneau, et al.
Pageof 19